2024-10-01 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis Report

**1. Performance Comparison:**

HCA Healthcare Inc. (HCA) is a leading provider of healthcare services in the United States. Over the period reviewed, HCA has outperformed the S&P 500 (VOO) by a significant margin. The cumulative return for HCA is 333.75%, while the S&P 500 has generated a cumulative return of 133.28%. This represents a difference of 200.47%, placing HCA at the 98.75th percentile of its historical performance relative to the S&P 500.

**2. Recent Price Movement:**

HCA's recent price action suggests some consolidation. 

* Closing Price: $404.16
* 5-Day Moving Average: $404.38
* 20-Day Moving Average: $397.34
* 60-Day Moving Average: $367.73

The stock is trading slightly below its 5-day moving average, indicating short-term weakness. However, it remains above its longer-term moving averages, suggesting a potential for continued upward momentum.

**3. Technical Indicators:**

* **RSI:**  77.16.  HCA's RSI is currently in overbought territory, suggesting the stock may be due for a correction.
* **PPO:** -0.19. This indicates a potential for a slowdown in the upward trend. 
* **Delta_Previous_Relative_Divergence:** -1.25.  A negative value suggests a short-term downtrend.
* **Expected_Return:** 0.17.  The estimated expected return is positive, indicating potential upside over the next five years.

**4. Recent Earnings and Outlook:**

HCA's recent earnings have been strong. However, the latest quarter's performance slightly missed analyst expectations.

| Date        | EPS      | Revenue           |
|--------------|----------|-------------------|
| 2024-07-29  | 5.6     | $17.49 Billion   |
| 2024-05-02  | 6.01    | $17.34 Billion   |
| 2023-10-26  | 3.98    | $16.21 Billion   |
| 2023-08-02  | 4.35    | $15.86 Billion   |
| 2024-07-29  | 4.35    | $15.86 Billion   |

**5. News and Recent Issues:**

**Recent Market Outlook:**

* **FINBOLD:** Recent reports indicate positive sentiment towards HCA, citing strong fundamentals and a favorable healthcare market outlook. Analysts highlight HCA's robust growth trajectory driven by increasing demand for healthcare services and an aging population.
* **Analyst Opinions:** Several analysts have issued Buy ratings for HCA, suggesting a bullish outlook on the company's future prospects. 

**Performance Highlights:**

* **Solid Financial Performance:** HCA has consistently delivered strong financial results, demonstrating its ability to navigate challenging market conditions.
* **Expanding Market Presence:** HCA continues to expand its footprint through strategic acquisitions and partnerships, solidifying its position as a market leader.
* **Focus on Innovation:** HCA is investing in technology and innovation to enhance patient care and optimize operational efficiency.

**6. Overall Analysis:**

HCA Healthcare Inc. is a strong performer with a robust track record of growth and profitability. The company's recent earnings have been positive, and its future prospects remain bright. However, the stock is currently in overbought territory, and recent price action suggests some consolidation may be in order. 

**7. Recommendation:**

HCA is a worthwhile consideration for long-term investors seeking exposure to the healthcare sector. While a potential correction may be on the horizon, the company's strong fundamentals and future growth prospects make it a compelling investment opportunity. However, it's important to monitor technical indicators and consider timing before making any investment decisions.
